BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35854676)

  • 1. HPV-CCDC106 integration promotes cervical cancer progression by facilitating the high expression of CCDC106 after HPV E6 splicing.
    Zhi W; Wei Y; Lazare C; Meng Y; Wu P; Gao P; Lin S; Peng T; Chu T; Liu B; Ding W; Cao C; Wu P
    J Med Virol; 2023 Jan; 95(1):e28009. PubMed ID: 35854676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV-CCDC106 integration alters local chromosome architecture and hijacks an enhancer by three-dimensional genome structure remodeling in cervical cancer.
    Cao C; Hong P; Huang X; Lin D; Cao G; Wang L; Feng B; Wu P; Shen H; Xu Q; Ren C; Meng Y; Zhi W; Yu R; Wei J; Ding W; Tian X; Zhang Q; Li W; Gao Q; Chen G; Li K; Sung WK; Hu Z; Wang H; Li G; Wu P
    J Genet Genomics; 2020 Aug; 47(8):437-450. PubMed ID: 33023834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    McFarlane M; MacDonald AI; Stevenson A; Graham SV
    J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERa-36 instead of ERa mediates the stimulatory effects of estrogen on the expression of viral oncogenes HPV E6/E7 and the malignant phenotypes in cervical cancer cells.
    Zhang X; Zhang A; Zhang X; Hu S; Bao Z; Zhang Y; Jiang X; He H; Zhang TC
    Virus Res; 2021 Dec; 306():198602. PubMed ID: 34662680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AIB1 is a novel target of the high-risk HPV E6 protein and a biomarker of cervical cancer progression.
    Miller J; Dakic A; Spurgeon M; Saenz F; Kallakury B; Zhao B; Zhang J; Zhu J; Ma Q; Xu Y; Lambert P; Schlegel R; Riegel AT; Liu X
    J Med Virol; 2022 Aug; 94(8):3962-3977. PubMed ID: 35437795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.
    Sathish N; Abraham P; Peedicayil A; Sridharan G; John S; Chandy G
    Mol Diagn; 2004; 8(1):57-64. PubMed ID: 15230643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of carcinogenesis by human papillomavirus-16.
    Ishiji T
    J Dermatol; 2000 Feb; 27(2):73-86. PubMed ID: 10721654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the p53 arginine/arginine homozygous genotype at codon 72 and human papillomavirus E6/E7 mRNA expression.
    Chuery ACS; Silva IDCGD; Ribalta JCL; Speck NMG
    Braz J Infect Dis; 2017; 21(3):248-254. PubMed ID: 28347732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
    Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
    Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic delivery of siRNA by actively targeted polyion complex micelles for silencing the E6 and E7 human papillomavirus oncogenes.
    Nishida H; Matsumoto Y; Kawana K; Christie RJ; Naito M; Kim BS; Toh K; Min HS; Yi Y; Matsumoto Y; Kim HJ; Miyata K; Taguchi A; Tomio K; Yamashita A; Inoue T; Nakamura H; Fujimoto A; Sato M; Yoshida M; Adachi K; Arimoto T; Wada-Hiraike O; Oda K; Nagamatsu T; Nishiyama N; Kataoka K; Osuga Y; Fujii T
    J Control Release; 2016 Jun; 231():29-37. PubMed ID: 26979870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR/Cas RNA-guided endonuclease.
    Kennedy EM; Kornepati AV; Goldstein M; Bogerd HP; Poling BC; Whisnant AW; Kastan MB; Cullen BR
    J Virol; 2014 Oct; 88(20):11965-72. PubMed ID: 25100830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear proinflammatory cytokine S100A9 enhances expression of human papillomavirus oncogenes via transcription factor TEAD1.
    Mori S; Ishii Y; Takeuchi T; Kukimoto I
    J Virol; 2023 Aug; 97(8):e0081523. PubMed ID: 37578237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV-16 E6 and E7 oncogene expression is downregulated as a result of Mdm2 knockdown.
    Diaz D; Santander MA; Chavez JA
    Int J Oncol; 2012 Jul; 41(1):141-6. PubMed ID: 22504553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of HPV integration, viral gene expression and E6E7 alternative transcripts by RNA-Seq: A descriptive study in invasive cervical cancer.
    Brant AC; Menezes AN; Felix SP; de Almeida LM; Sammeth M; Moreira MAM
    Genomics; 2019 Dec; 111(6):1853-1861. PubMed ID: 30552977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells.
    Lee K; Lee AY; Kwon YK; Kwon H
    Biochem Biophys Res Commun; 2011 Aug; 412(2):328-33. PubMed ID: 21821000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
    Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
    Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV E6/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m
    Hu C; Liu T; Han C; Xuan Y; Jiang D; Sun Y; Zhang X; Zhang W; Xu Y; Liu Y; Pan J; Wang J; Fan J; Che Y; Huang Y; Zhang J; Ding J; Yang S; Yang K
    Int J Biol Sci; 2022; 18(2):507-521. PubMed ID: 35002506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic HPV promotes the expression of the long noncoding RNA lnc-FANCI-2 through E7 and YY1.
    Liu H; Xu J; Yang Y; Wang X; Wu E; Majerciak V; Zhang T; Steenbergen RDM; Wang HK; Banerjee NS; Li Y; Lu W; Meyers C; Zhu J; Xie X; Chow LT; Zheng ZM
    Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33436409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
    Munagala R; Aqil F; Jeyabalan J; Gupta RC
    Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.